Despite the increasing number of ectoparasiticides for pets and their use, flea infestations of cats and dogs are still widespread in Europe. It is therefore important to assess the maintenance of efficacy of the ectoparasiticides for cats and dogs. The present studies aimed to evaluate the efficacy of monthly treatments using a fipronil/(S)-methoprene combination spot-on (Frontline Combo®) on dogs and cats from private veterinary clinics located in seven European countries. The survey was conducted for three months during the flea season 2009. A total of 233 dogs and 180 cats were included. Each animal was treated at Days 0 (Day 0), 30 (D30) and 60 (D60) at the vet clinics. For each animal, at least three flea counts were performed at D0, ...
Abstract Background Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazo...
A new fipronil-based spot-on formulation applied once to dogs was evaluated against experimental fl...
Abstract Background The objective of these two GCP multicentre European clinical field studies was t...
ABSTRACT: The study was conducted in order to evaluate the effect of a fipronil/(S)-methoprene formu...
Two studies were performed to evaluate the effectiveness of two monthly topical anti-flea products f...
Abstract Background Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats an...
In the study reported here, the pioneer fipronil/(S)-methoprene topical product (FRONTLINE® PLUS, Me...
Background: A study was conducted to evaluate and compare the effectiveness of two different spot-...
Flea infestations of pets continue to persist due to the lack of knowledge of flea biology and ecolo...
In the study reported here, the pioneer fipronil/(S)-methoprene topical product (FRONTLINE® PLUS, Me...
Two studies were performed to evaluate the effectiveness of two monthly topical anti-flea products f...
Flea infestations of pets continue to persist due to the lack of knowledge of flea biology and ecolo...
AbstractThe efficacy of a novel topical combination of fipronil 8.3% (w/v), (S)-methoprene 10% (w/v)...
Flea infestations of pets continue to persist due to the lack of knowledge of flea biology and ecolo...
Abstract Background A large number of fleas parasitize dogs living with sheep in Greece. The primary...
Abstract Background Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazo...
A new fipronil-based spot-on formulation applied once to dogs was evaluated against experimental fl...
Abstract Background The objective of these two GCP multicentre European clinical field studies was t...
ABSTRACT: The study was conducted in order to evaluate the effect of a fipronil/(S)-methoprene formu...
Two studies were performed to evaluate the effectiveness of two monthly topical anti-flea products f...
Abstract Background Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats an...
In the study reported here, the pioneer fipronil/(S)-methoprene topical product (FRONTLINE® PLUS, Me...
Background: A study was conducted to evaluate and compare the effectiveness of two different spot-...
Flea infestations of pets continue to persist due to the lack of knowledge of flea biology and ecolo...
In the study reported here, the pioneer fipronil/(S)-methoprene topical product (FRONTLINE® PLUS, Me...
Two studies were performed to evaluate the effectiveness of two monthly topical anti-flea products f...
Flea infestations of pets continue to persist due to the lack of knowledge of flea biology and ecolo...
AbstractThe efficacy of a novel topical combination of fipronil 8.3% (w/v), (S)-methoprene 10% (w/v)...
Flea infestations of pets continue to persist due to the lack of knowledge of flea biology and ecolo...
Abstract Background A large number of fleas parasitize dogs living with sheep in Greece. The primary...
Abstract Background Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazo...
A new fipronil-based spot-on formulation applied once to dogs was evaluated against experimental fl...
Abstract Background The objective of these two GCP multicentre European clinical field studies was t...